The diagnosis for these patients can however be difficult and KCNJ2 should be included in the panel of genes used to identify molecular causes of arrhythmias, in particular to adapt CPVT patient care. The gene discussed is KCNJ2; the disease is catecholaminergic polymorphic ventricular tachycardia.